BIO-TECHNE Corp Other Income and Expense
BIO-TECHNE Corp (TECH) reported Other Income and Expense of -$11.21 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-08-24
- BIO-TECHNE Corp nonoperating income (expense) for the quarter ending 2026-06-30 was -$3.60M, a 459.24% decline year-over-year.
- BIO-TECHNE Corp nonoperating income (expense) for the quarter ending 2026-03-31 was -$4.27M.
- BIO-TECHNE Corp nonoperating income (expense) for the quarter ending 2025-12-31 was -$3.68M.
- BIO-TECHNE Corp nonoperating income (expense) for the quarter ending 2025-09-30 was $333.00K, a 80.98% increase year-over-year.
- BIO-TECHNE Corp nonoperating income (expense) for fiscal 2026 was -$11.21M.
- BIO-TECHNE Corp nonoperating income (expense) for fiscal 2025 was -$3.79M.
- BIO-TECHNE Corp nonoperating income (expense) for fiscal 2024 was -$21.00M, a 152.87% decline from fiscal 2023.
- BIO-TECHNE Corp nonoperating income (expense) for fiscal 2023 was $39.72M, a 728.09% increase from fiscal 2022.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 3 month as first filed | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 6 month as first filed | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 9 month as first filed | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | -$7.87M derived: sum of 2 quarters · filed 2026-08-24 | -$11.54M derived: sum of 3 quarters · filed 2026-08-24 | -$11.21M 10-K · filed 2026-08-24 | |||
| 2026-03-31 | -$4.27M 10-Q · filed 2026-05-06 | -$7.95M derived: sum of 2 quarters · filed 2026-05-06 | -$7.61M 10-Q · filed 2026-05-06 | -$6.61M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2025-12-31 | -$3.68M 10-Q · filed 2026-02-04 | -$3.34M 10-Q · filed 2026-02-04 | -$2.34M derived: sum of 3 quarters · filed 2026-08-24 | -$2.78M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2025-09-30 | $333.00K 10-Q · filed 2025-11-05 | $1.33M derived: sum of 2 quarters · filed 2026-08-24 | $900.00K derived: sum of 3 quarters · filed 2026-08-24 | -$3.64M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2025-06-30 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $567.00K derived: sum of 2 quarters · filed 2026-08-24 | -$3.98M derived: sum of 3 quarters · filed 2026-08-24 | -$3.79M 10-K · filed 2026-08-24 | |||
| 2025-03-31 | -$434.00K 10-Q · filed 2026-05-06 | -$4.98M derived: sum of 2 quarters · filed 2026-05-06 | -$4.79M 10-Q · filed 2026-05-06 | -$8.96M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2024-12-31 | -$4.54M 10-Q · filed 2026-02-04 | -$4.36M 10-Q · filed 2026-02-04 | -$8.52M derived: sum of 3 quarters · filed 2026-08-24 | -$14.44M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2024-09-30 | $184.00K 10-Q · filed 2025-11-05 | -$3.98M derived: sum of 2 quarters · filed 2026-08-24 | -$9.89M derived: sum of 3 quarters · filed 2026-08-24 | -$14.51M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2024-06-30 | -$4.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | -$10.08M derived: sum of 2 quarters · filed 2026-08-24 | -$14.69M derived: sum of 3 quarters · filed 2026-08-24 | -$21.00M 10-K · filed 2026-08-24 | |||
| 2024-03-31 | -$5.91M 10-Q · filed 2025-05-08 | -$10.53M derived: sum of 2 quarters · filed 2025-05-08 | -$16.84M 10-Q · filed 2025-05-08 | -$23.04M derived: sum of 4 quarters · filed 2025-08-22 | |||
| 2023-12-31 | -$4.62M 10-Q · filed 2025-02-06 | -$10.92M 10-Q · filed 2025-02-06 | -$17.13M derived: sum of 3 quarters · filed 2025-08-22 | -$17.14M derived: sum of 4 quarters · filed 2025-08-22 | |||
| 2023-09-30 | -$6.30M 10-Q · filed 2024-11-05 | -$12.51M derived: sum of 2 quarters · filed 2025-08-22 | -$12.53M derived: sum of 3 quarters · filed 2025-08-22 | -$13.99M derived: sum of 4 quarters · filed 2025-08-22 | |||
| 2023-06-30 | -$6.21M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | -$6.22M derived: sum of 2 quarters · filed 2025-08-22 | -$7.69M derived: sum of 3 quarters · filed 2025-08-22 | $39.72M 10-K · filed 2025-08-22 | |||
| 2023-03-31 | -$15.00K 10-Q · filed 2024-05-06 | -$1.48M derived: sum of 2 quarters · filed 2024-05-06 | $45.92M 10-Q · filed 2024-05-06 | $44.40M derived: sum of 4 quarters · filed 2024-08-22 | |||
| 2022-12-31 | -$1.46M 10-Q · filed 2024-02-07 | $45.94M 10-Q · filed 2024-02-07 | $44.42M derived: sum of 3 quarters · filed 2024-08-22 | $22.74M derived: sum of 4 quarters · filed 2024-08-22 | |||
| 2022-09-30 | $47.40M 10-Q · filed 2023-11-07 | $45.88M derived: sum of 2 quarters · filed 2024-08-22 | $24.20M derived: sum of 3 quarters · filed 2024-08-22 | $48.03M derived: sum of 4 quarters · filed 2024-08-22 | |||
| 2022-06-30 | -$1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-22 | -$23.20M derived: sum of 2 quarters · filed 2024-08-22 | $635.00K derived: sum of 3 quarters · filed 2024-08-22 | $4.80M 10-K · filed 2024-08-22 | |||
| 2022-03-31 | -$21.68M 10-Q · filed 2023-05-08 | $2.16M derived: sum of 2 quarters · filed 2023-05-08 | $6.32M 10-Q · filed 2023-05-08 | -$55.15M derived: sum of 4 quarters · filed 2023-08-23 | |||
| 2021-12-31 | $23.83M 10-Q · filed 2023-02-07 | $27.99M 10-Q · filed 2023-02-07 | -$33.48M derived: sum of 3 quarters · filed 2023-08-23 | -$56.75M derived: sum of 4 quarters · filed 2023-08-23 | |||
| 2021-09-30 | $4.16M 10-Q · filed 2022-11-07 | -$57.31M derived: sum of 2 quarters · filed 2023-08-23 | -$80.58M derived: sum of 3 quarters · filed 2023-08-23 | -$75.21M derived: sum of 4 quarters · filed 2023-08-23 | |||
| 2021-06-30 | -$61.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | -$84.74M derived: sum of 2 quarters · filed 2023-08-23 | -$79.37M derived: sum of 3 quarters · filed 2023-08-23 | -$89.12M 10-K · filed 2023-08-23 | |||
| 2021-03-31 | -$23.27M 10-Q · filed 2022-05-09 | -$17.90M derived: sum of 2 quarters · filed 2022-05-09 | -$27.65M 10-Q · filed 2022-05-09 | -$5.44M derived: sum of 4 quarters · filed 2022-08-24 | |||
| 2020-12-31 | $5.37M 10-Q · filed 2022-02-07 | -$4.38M 10-Q · filed 2022-02-07 | $17.84M derived: sum of 3 quarters · filed 2022-08-24 | $16.86M derived: sum of 4 quarters · filed 2022-08-24 | |||
| 2020-09-30 | -$9.75M 10-Q · filed 2021-11-08 | $12.46M derived: sum of 2 quarters · filed 2022-08-24 | $11.49M derived: sum of 3 quarters · filed 2022-08-24 | $124.83M derived: sum of 4 quarters · filed 2022-08-24 | |||
| 2020-06-30 | $22.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-24 | $21.25M derived: sum of 2 quarters · filed 2022-08-24 | $134.58M derived: sum of 3 quarters · filed 2022-08-24 | $119.06M 10-K · filed 2022-08-24 | |||
| 2020-03-31 | -$970.00K 10-Q · filed 2021-05-07 | $112.36M derived: sum of 2 quarters · filed 2021-05-07 | $96.84M 10-Q · filed 2021-05-07 | $76.36M derived: sum of 4 quarters · filed 2021-08-25 | |||
| 2019-12-31 | $113.33M 10-Q · filed 2021-02-08 | $97.81M 10-Q · filed 2021-02-08 | $77.33M derived: sum of 3 quarters · filed 2021-08-25 | $83.12M derived: sum of 4 quarters · filed 2021-08-25 | |||
| 2019-09-30 | -$15.52M 10-Q · filed 2020-11-09 | -$36.00M derived: sum of 2 quarters · filed 2021-08-25 | -$30.21M derived: sum of 3 quarters · filed 2021-08-25 | -$42.05M derived: sum of 4 quarters · filed 2021-08-25 | |||
| 2019-06-30 | -$20.48M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-25 | -$14.69M derived: sum of 2 quarters · filed 2021-08-25 | -$26.53M derived: sum of 3 quarters · filed 2021-08-25 | -$34.70M 10-K · filed 2021-08-25 | |||
| 2019-03-31 | $5.79M 10-Q · filed 2020-05-11 | -$6.05M derived: sum of 2 quarters · filed 2020-05-11 | -$14.23M 10-Q · filed 2020-05-11 | -$871.00K derived: sum of 4 quarters · filed 2020-08-26 | |||
| 2018-12-31 | -$11.84M 10-Q · filed 2020-02-06 | -$20.01M 10-Q · filed 2020-02-06 | -$6.66M derived: sum of 3 quarters · filed 2020-08-26 | -$24.76M derived: sum of 4 quarters · filed 2020-08-26 | |||
| 2018-09-30 | -$8.18M 10-Q · filed 2019-11-06 | $5.18M derived: sum of 2 quarters · filed 2020-08-26 | -$12.92M derived: sum of 3 quarters · filed 2020-08-26 | -$15.34M derived: sum of 4 quarters · filed 2020-08-26 | |||
| 2018-06-30 | $13.36M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-26 | -$4.75M derived: sum of 2 quarters · filed 2020-08-26 | -$7.16M derived: sum of 3 quarters · filed 2020-08-26 | -$10.23M 10-K · filed 2020-08-26 | |||
| 2018-03-31 | -$18.10M 10-Q · filed 2019-05-07 | -$20.52M derived: sum of 2 quarters · filed 2019-05-07 | -$23.58M 10-Q · filed 2019-05-07 | -$25.78M derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2017-12-31 | -$2.42M 10-Q · filed 2019-02-07 | -$5.48M 10-Q · filed 2019-02-07 | -$7.68M derived: sum of 3 quarters · filed 2019-11-06 | -$10.04M derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2017-09-30 | -$3.06M 10-Q · filed 2018-11-07 | -$5.26M derived: sum of 2 quarters · filed 2019-11-06 | -$7.62M derived: sum of 3 quarters · filed 2019-11-06 | -$10.32M derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2017-06-30 | -$2.20M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06 | -$4.56M derived: sum of 2 quarters · filed 2019-11-06 | -$7.25M derived: sum of 3 quarters · filed 2019-11-06 | -$8.62M 10-K/A · filed 2019-11-06 | |||
| 2017-03-31 | -$2.36M 10-Q · filed 2018-05-09 | -$2.27M 10-Q · filed 2017-05-10 | -$5.05M derived: sum of 2 quarters · filed 2018-05-09 | -$6.42M 10-Q · filed 2018-05-09 | -$6.20M 10-Q · filed 2017-05-10 | -$8.67M derived: sum of 4 quarters · filed 2018-08-27 | |
| 2016-12-31 | -$2.69M 10-Q · filed 2018-02-08 | -$2.61M 10-Q · filed 2017-02-09 | -$4.06M 10-Q · filed 2018-02-08 | -$3.92M 10-Q · filed 2017-02-09 | -$6.31M derived: sum of 3 quarters · filed 2018-08-27 | -$7.34M derived: sum of 4 quarters · filed 2018-08-27 | |
| 2016-09-30 | -$1.37M 10-Q · filed 2017-11-09 | -$1.31M 10-Q · filed 2016-11-09 | -$3.61M derived: sum of 2 quarters · filed 2018-08-27 | -$4.65M derived: sum of 3 quarters · filed 2018-08-27 | -$5.30M derived: sum of 4 quarters · filed 2018-08-27 | ||
| 2016-06-30 | -$2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-27 | -$3.28M derived: sum of 2 quarters · filed 2018-08-27 | -$3.93M derived: sum of 3 quarters · filed 2018-08-27 | -$3.11M 10-K · filed 2018-08-27 | |||
| 2016-03-31 | -$1.04M 10-Q · filed 2017-05-10 | -$1.69M derived: sum of 2 quarters · filed 2017-05-10 | -$870.00K 10-Q · filed 2017-05-10 | -$429.00K derived: sum of 4 quarters · filed 2017-09-07 | |||
| 2015-12-31 | -$651.00K 10-Q · filed 2017-02-09 | $167.00K 10-Q · filed 2017-02-09 | $608.00K derived: sum of 3 quarters · filed 2017-09-07 | -$59.00K derived: sum of 4 quarters · filed 2017-09-07 | |||
| 2015-09-30 | $818.00K 10-Q · filed 2016-11-09 | $1.26M derived: sum of 2 quarters · filed 2017-09-07 | $592.00K derived: sum of 3 quarters · filed 2017-09-07 | $8.57M derived: sum of 4 quarters · filed 2017-09-07 | |||
| 2015-06-30 | $441.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | -$226.00K derived: sum of 2 quarters · filed 2017-09-07 | $7.76M derived: sum of 3 quarters · filed 2017-09-07 | $7.14M 10-K · filed 2017-09-07 | |||
| 2015-03-31 | -$667.00K 10-Q · filed 2016-05-10 | $7.32M derived: sum of 2 quarters · filed 2016-05-10 | $6.70M 10-Q · filed 2016-05-10 | $7.30M derived: sum of 4 quarters · filed 2016-08-29 | |||
| 2014-12-31 | $7.98M 10-Q · filed 2016-02-09 | $7.37M 10-Q · filed 2016-02-09 | $7.97M derived: sum of 3 quarters · filed 2016-08-29 | $8.27M derived: sum of 4 quarters · filed 2016-08-29 | |||
| 2014-09-30 | -$618.00K 10-Q · filed 2015-11-09 | -$13.00K derived: sum of 2 quarters · filed 2016-08-29 | $287.00K derived: sum of 3 quarters · filed 2016-08-29 | $761.00K derived: sum of 4 quarters · filed 2016-08-29 | |||
| 2014-06-30 | $605.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29 | $905.00K derived: sum of 2 quarters · filed 2016-08-29 | $1.38M derived: sum of 3 quarters · filed 2016-08-29 | $1.64M 10-K · filed 2016-08-29 | |||
| 2014-03-31 | $300.00K 10-Q · filed 2015-05-11 | $774.00K derived: sum of 2 quarters · filed 2015-05-11 | $1.04M 10-Q · filed 2015-05-11 | $1.99M derived: sum of 4 quarters · filed 2015-08-31 | |||
| 2013-12-31 | $474.00K 10-Q · filed 2015-02-09 | $737.00K 10-Q · filed 2015-02-09 | $1.69M derived: sum of 3 quarters · filed 2015-08-31 | $2.21M derived: sum of 4 quarters · filed 2015-08-31 | |||
| 2013-09-30 | $263.00K 10-Q · filed 2014-11-10 | $1.21M derived: sum of 2 quarters · filed 2015-08-31 | $1.73M derived: sum of 3 quarters · filed 2015-08-31 | $2.27M derived: sum of 4 quarters · filed 2015-08-31 | |||
| 2013-06-30 | $948.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31 | $1.47M derived: sum of 2 quarters · filed 2015-08-31 | $2.01M derived: sum of 3 quarters · filed 2015-08-31 | $2.19M 10-K · filed 2015-08-31 | |||
| 2013-03-31 | $520.00K 10-Q · filed 2014-05-12 | $1.06M derived: sum of 2 quarters · filed 2014-05-12 | $1.25M 10-Q · filed 2014-05-12 | $644.00K derived: sum of 4 quarters · filed 2014-08-29 | |||
| 2012-12-31 | $542.00K 10-Q · filed 2014-02-04 | $725.00K 10-Q · filed 2014-02-04 | $124.00K derived: sum of 3 quarters · filed 2014-08-29 | -$3.03M derived: sum of 4 quarters · filed 2014-08-29 | |||
| 2012-09-30 | $183.00K 10-Q · filed 2013-11-12 | -$418.00K derived: sum of 2 quarters · filed 2014-08-29 | -$3.58M derived: sum of 3 quarters · filed 2014-08-29 | -$3.38M derived: sum of 4 quarters · filed 2014-08-29 | |||
| 2012-06-30 | -$601.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-29 | -$3.76M derived: sum of 2 quarters · filed 2014-08-29 | -$3.57M derived: sum of 3 quarters · filed 2014-08-29 | -$4.01M 10-K · filed 2014-08-29 | |||
| 2012-03-31 | -$3.16M 10-Q · filed 2013-05-10 | -$2.97M derived: sum of 2 quarters · filed 2013-05-10 | -$3.41M 10-Q · filed 2013-05-10 | -$3.04M derived: sum of 4 quarters · filed 2013-08-29 | |||
| 2011-12-31 | $191.00K 10-Q · filed 2013-02-11 | -$256.00K 10-Q · filed 2013-02-11 | $112.00K derived: sum of 3 quarters · filed 2013-08-29 | $758.00K derived: sum of 4 quarters · filed 2013-08-29 | |||
| 2011-09-30 | -$447.00K 10-Q · filed 2012-11-09 | -$79.00K derived: sum of 2 quarters · filed 2013-08-29 | $567.00K derived: sum of 3 quarters · filed 2013-08-29 | $889.00K derived: sum of 4 quarters · filed 2013-08-29 | |||
| 2011-06-30 | $368.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29 | $1.01M derived: sum of 2 quarters · filed 2013-08-29 | $1.34M derived: sum of 3 quarters · filed 2013-08-29 | $1.93M 10-K · filed 2013-08-29 | |||
| 2011-03-31 | $646.00K 10-Q · filed 2012-05-10 | $968.00K derived: sum of 2 quarters · filed 2012-05-10 | $1.56M 10-Q · filed 2012-05-10 | $1.23M derived: sum of 4 quarters · filed 2012-08-29 | |||
| 2010-12-31 | $322.00K 10-Q · filed 2012-02-07 | $912.00K 10-Q · filed 2012-02-07 | $588.00K derived: sum of 3 quarters · filed 2012-08-29 | $379.00K derived: sum of 4 quarters · filed 2012-08-29 | |||
| 2010-09-30 | $590.00K 10-Q · filed 2011-11-09 | $266.00K derived: sum of 2 quarters · filed 2012-08-29 | $57.00K derived: sum of 3 quarters · filed 2012-08-29 | $202.00K derived: sum of 4 quarters · filed 2012-08-29 | |||
| 2010-06-30 | -$324.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-29 | -$533.00K derived: sum of 2 quarters · filed 2012-08-29 | -$388.00K derived: sum of 3 quarters · filed 2012-08-29 | $118.00K 10-K · filed 2012-08-29 | |||
| 2010-03-31 | -$209.00K 10-Q · filed 2011-05-10 | -$64.00K derived: sum of 2 quarters · filed 2011-05-10 | $442.00K 10-Q · filed 2011-05-10 | ||||
| 2009-12-31 | $145.00K 10-Q · filed 2011-02-09 | $651.00K 10-Q · filed 2011-02-09 | |||||
| 2009-09-30 | $506.00K 10-Q · filed 2010-11-09 | ||||||
| 2009-06-30 | $4.58M 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |